Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-035958

Chief Executive Officer sold 56,436 shares at $9.05 ($510,808)

  • Chief Executive Officer acquired 31,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gibson Christopher · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Exercise or conversion : show line 1 in the form +31,250 $2.48 $77,500 972,814 D
2023-06-07 Sale : show line 2 in the form −56,436 $9.05 $510,808 916,378 D
Open-market sales · 56,436 sh · avg $9.05 · $510,808

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-06-07 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −31,250 $2.48 2030-12-30 31,250 593,750 D
Loading xslF345X04/doc4.xml…